Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Medications > Vasopressors > Flashcards

Vasopressors Flashcards

1
Q

Dobutamine

(mechanism of action)

A

♦ Inotrope ♦

♦ Stimulates

beta 1+++++ = ⇡ heart rate and stroke volume (inotropy/chronotropy) = increased cardiac output

beta 2+++ vasodilates arteries = decreased SVR (afterload)

alpha 1 + vasoconstriction of arteries = increased SVR (afterload)

(if heart is already working as hard as it can, the secondary effect may be dominant, causing a drop in blood pressure)

⇔used alone, effect unpredictable⇔

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dobutamine

(onset / duration)

A

♦ Onset 1 - 2 minutes

(may take up to 10 min for peak effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dobutamine

(side effects)

A

Tachycardia

Ventricular Ectopy / Palpitations

Headache

Nausea/Vomiting

Hypertension/Hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dobutamine

(indications)

A

Cardiogenic Shock associated with Hypotension

(as an add-on or secondary med)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dobutamine

(contraindications)

A

Hypersensitivity

* use with caution in pt’s with AMI, unstable angina, or severe CAD, as dobutamine can intensify or extend myocardial ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dobutamine

(adult dose)

A

2 - 20 mcg/kg/min IV/IO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dobutamine

(pediatric dose)

A

2 - 20 mcg/kg/min IV/IO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dobutamine

(pregnancy safe)

A

Class C

No adequate or well-controlled studies have been conducted in pregnant women. Use dobutamine during pregnancy only when the expected benefits clearly outweigh the potential risks to the fetus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Dopamine

(mechanism of action)

A

Stimulates:

beta 1 ++++ inotrophy / chronotropy = increased cardiac output

beta 2 ++ vasodilate arteries = decreased SVR (afterload)

alpha 1 +++ → vasoconstriction = increased SVR (afterload)

(stronger effect on cardiac output than it does on SVR [afterload])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dopamine

(onset and duration)

A

Onset 2 - 5 mins

Duration < 10 min (after stopping infusion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dopamine

(side effects)

A

Tachydysrhythmias / Ectopy

Headache

Angina

Nausea/Vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dopamine

(indications)

A

Cardiogenic Shock associated with Hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dopamine

(contraindications)

A

♦ Hypovolemic Shock where Complete Fluid Resuscitation has NOT Occurred

♦ Uncorrected Tachydysrhythmias or V-fib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dopamine

(adult dose)

A

2 - 20 mcg/kg/min IV/IO

1600 mcg/mL concentration

  • ♦ 1-5 mcg/kg/min - mainly affects renal arteries*
  • ♦ 5-20 mcg/kg/min - inotropic / chronotropic and systemic vasoconstriction*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dopamine

(pediatric dose)

A

2 - 20 mcg/kg/min IV/IO

1600 mcg/mL concentration

(same as adult)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dopamine

(pregnancy safe)

A

Class C

Use is recommended only if clearly needed and the benefit outweighs the risk to the fetus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Epinephrine Infusion

(mechanism of action)

A

Stimulation of:

beta 1++++ ⇡ heart rate and stroke volume = increased cardiac output

beta 2+++ vasodilation of arteries = decreased SVR (afterload)

alpha1+++++ pure vasoconstriction of arteries = increase in SVR (afterload)

  • (indirectly causes coronary artery vasodilation)*
  • (dose for dose, Epi will increase cardiac output MORE than Norepi)*
  • (Epi + Dopamine will increase cardiac output BUT maintain SVR, which increases MAP)*
  • (Norepi will increase SVR AND maintain cardiac output, which increases MAP)*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Epinephrine

Push Dose Pressor

(onset / duration)

A

Onset < 1 min

Duration +/- 5 - 10 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Epinephrine

(side effects)

A

Palpitations

Hypertension

Dysrhythmias

Anxiety

Tremors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Epinephrine

(indications)

A

V - Fib / Pulseless V - Tach

Asystole / PEA

Anaphylaxis

Bronchospasm

Hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Epinephrine

(contraindications)

A

None Listed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Epinephrine

Anaphylactic Shock / Allergic Reaction

(adult dose)

A

♦ 0.3 – 0.5 mg 1:1,000 solution IM

♦ May be repeated every 20 minutes up to three times for a total of 4 doses

♦ If patient is hemodynamically unstable, administer 1:10,000 solution up to 0.5mg IO/IV.

Titrate to effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Epinephrine

Anaphylactic Shock / Allergic Reaction

(pediatric dose)

A

♦ 0.01 mg/kg 1:1,000 IM max 0.5 mg

→ may repeat q 20 mins for a total of 4 doses

♦ Hemodynamically Unstable → 1:10,000 0.01 mg/kg

up to 0.5 mg IV/IO titrate to effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Epinephrine

(pregnancy safe)

A

Class C

Epinephrine is only recommended for use during pregnancy when benefit outweighs risk.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Norepinephrine (Levophed)

(mechanism of action)

A

Stimulates:

beta 1+++ ⇡ HR and stroke volume = increased cardiac output

beta 2++ vasodilation of the arteries = decreased SVR (afterload)

alpha 1+++++ vasoconstriction of the arteries = increased SVR (afterload)

(stronger effect on SVR than on cardiac output)

(increases SVR while maintaining or slightly increasing cardiac output)

(good broad spectrum vasoactive agent when it’s unclear what is going on)

26
Q

Norepinephrine (Levophed)

(onset / duration)

A
27
Q

Norepinephrine (Levophed)

(side effects)

A

Tissue Hypoxia

Brardycardia (increase in afterload from α-1 stimulation results in a reflex bradycardia)

Anxiety

Headache

Respiratory Difficulty

Extravasation Necrosis

28
Q

Norepinephrine (Levophed)

(indications)

A

>>Hypotension<<

»Septic Shock«

29
Q

Norepinephrine (Levophed)

(contraindications)

A

♦ Hypotension From Blood Volume Deficits

♦ Mesenteric or Peripheral Vascular Thrombosis

30
Q

Norepinephrine (Levophed)

(adult dose)

A

2 - 20 mcg/min IV/IO

Titrate every 3 - 5 mins

31
Q

Norepinephrine (Levophed)

(pediatric dose)

A

0.1 - 2 mcg/kg/min

Titrate every 3 - 5 mins

32
Q

Norepinephrine (Levophed)

(pregnancy safe)

A

Category C

Use is recommended only if clearly needed and the benefit outweighs the risk

(Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans)

33
Q

Phenylephrine (Neo-Synephrine)

(mechanism of action)

A

♦ Pure α-1 adrenergic receptor agonist

♦ Increases SVR (afterload) =** increased MAP, and **total peripheral vascular resistance

Effect on cardiac output depends on preload-responsiveness versus the ability of the heart to handle increased afterload.(example, a patient with systolic heart failure and volume overload, added preload won’t help, whereas the heart may be unable to tolerate afterload – so the net effect is to reduce the cardiac output. Alternatively, for a patient who is preload-responsive with a stronger ejection fraction, phenylephrine could cause a net increase in cardiac output.)

34
Q

Phenylephrine (Neo-Synephrine)

Push Dose Pressor

(onset / duration)

A

Onset < 1 min

Duration +/- 10 - 20 min

35
Q

Phenylephrine (Neo-Synephrine)

(side effects)

A

♦ Hypertension

♦ Bradycardia (as mean arterial pressure increases, vagal activity also increases, resulting in reflex bradycardia)

♦ Headache

♦ Dizziness

♦ Dysrhythmias

(**also causes vasoconstriction of coronary arteries**)

36
Q

Phenylephrine (Neo-Synephrine)

(indications)

A

♦ Hypotension

♦ Neurogenic Shock

♦ Spinal Shock (below level of T-6)

(preferred PD pressor in presence of tachycardia)

37
Q

Phenylephrine (Neo-Synephrine)

(contraindications)

A

>> Hypovolemia <<

38
Q

Phenylephrine (Neo-Synephrine)

(adult infusion dose)

A

40 - 180 mcg/min IV/IO

39
Q

Phenylephrine (Neo-Synephrine)

(pediatric infusion dose)

A

0.1 - 0.5 mcg/kg/min

40
Q

Phenylephrine (Neo-Synephrine)

(pregnancy safe)

A

Category C

Should be given to a pregnant woman only if the potential benefit justifies the potential risk to the fetus.

41
Q

Epinephrine

Asystole / PEA / V-fib / V-Tach

(adult dose)

A

1 mg 1:10,000 solution IO/IV every 3 – 5 minutes

until ROSC

42
Q

Epinephrine

Bradycardia / Medical Hypotension

(adult dose)

A

Set drip at 0.5 – 10 mcg/min IO/IV

43
Q

Epinephrine

Push Dose

(adult and pediatric dose)

A

♦ Push Dose 5 - 20 mcg / 0.5 - 2 mL q 2 - 5 min

44
Q

Epinephrine

Push Dose Mixing Instructions

(adult and pediatric)

A

Mixing

Take 10 mL syringe with 9 mL NS. Draw up 1 mL (0.1 mg) of 1:10,000 Epi from a pre-mixed vial. (concentration is 10 mcg/mL)

OR

Take 1 mL 1:1,000 Epi and mix in a 100 mL bag of NS

(resulting concentration is also 10 mcg/mL 1:1,000 Epi

45
Q

Epinephrine

Reactive Airway Disease

(adult dose)

A

0.3 mg 1:1,000 solution IM

46
Q

Epinephrine

Reactive Airway Disease

(pediatric dose)

A

0.1 mg/kg 1:1,000 solution IM

47
Q

Phenylephrine (Neo-Synephrine)

Push Dose

(adult and pediatric dose)

A

50 - 200 mcg (0.5 - 2 mL)

q 2 - 5 min

48
Q

Phenylephrine (Neo-Synephrine)

Push Dose

(mixing instructions)

A

Take a 3mL syringe, draw up 1 mL Phenylephrine with 10 mg/mL concentration

Inject this into a 100 mL bag NS

Resulting concentration is 100 mcg/mL

Alternatively

take 1 mL 1:1,000 Epi and mix into 100 mL bag NS

= 10 mcg/mL Epi 1:100,000 concentration

49
Q

Examples of Inotrope Medications Include

A

Digoxin - increased contractility

Dopamine - increased contractility

(also increases heart rate)

Dobutamine - increased contractility

(also increases heart rate)

Milrinone - increased contractility

50
Q

When is Dopamine useful?

A

Hypotension likely caused by vasodilation due to cardiac arrest, anaphylaxis, or sepsis, or when the heart is not contracting hard enough or fast enough.

Must give fluids FIRST

Also used in heart block and bradycardia in order to help maintain blood pressure and increase the heart rate.

NOT first-line in sepsis or anaphylaxis.

51
Q

Problems Associated With Dopamine

A

♦ Ionotropic effects can cause increased oxygen demand / increased contractility can cause HTN

♦ Chronotropic effects can cause dysrhythmias if multiple pacemaker cells are stimulated at once

♦ Abdominal pain/nausea/vomiting come from vasoconstriction in the gastrointestinal system

52
Q

Cardiogenic Shock =

A

Pump Failure/Sick Heart

(low stroke volume from low ejection fraction or MI that is impairing ejection fraction)

53
Q

Cardiogenic Shock Effects on

CO/SVR/CVP

A

Cardiac output: Decreased

Afterload (SVR): Increased

Preload (CVP): Increased (JVD, Pulmonary edema)

54
Q

Cardiogenic Shock Treatment Goal

A

Increase cardiac output AND Decrease SVR (afterload)

¤ (Be careful - decreasing SVR (afterload) in an already sick heart/hypotension may reduce pressure even further)

55
Q

Phenylephrine is not a good choice for cardiogenic shock because?

A

Phenylephrine is alpha only (⇡ SVR)

(Afterload (SVR) is already increased, further increases in afterload (SVR) may worsen stroke volume, leading to a further reduction in cardiac output)

56
Q

Why would Epi not be the best first-line med choice for cardiogenic shock?

A

Epi has strong beta-1 (inotropic/chronotropic) stimulation, increases cardiac output but maintains afterload (SVR)

(ie. increased myocardial oxygen demand to an already stressed heart compared to norepi)

57
Q

Is Phenylephrine a Good Choice for Use in Cardiogenic Shock?

Why?

A

NO

Phenylephrine is pure Alpha which causes arterial constriction. (increased afterload/SVR)

Since SVR (afterload) is already increased due to the shock state, increasing SVR (afterload) more, may worsen stroke volume, leading to a further reduction in cardiac output.

58
Q

Distributive Shock Effects on

CO/SV/SVR

(ie. sepsis / anaphylaxis)

A

Cardiac Output: decreased/normal, or slightly increased

Stroke Volume: decreased, or no change

SVR (afterload): decreased

Heart Rate: increased

(decreased afterload and preload = decreased stroke volume and cardiac output)

59
Q

Distributive Shock is Caused by?

A

Inflammation making the blood vessels “leaky”, causing fluid to leak into the interstitial spaces

(preload is the most sensitive to volume changes)

The inflammation of the arterial system initiates histamine release causing dilation of the peripheral arteries which decreases afterload and then preload.

Decreased preload ⇢ causes a decrease in stroke volume ⇢ decreased stroke volume causes an increase in HR in attempt to maintain cardiac output.

60
Q

What Is The First Intervention When Treating Septic Shock?

A

Volume Expansion

ie. Fluid Bolus

30mL/kg

(the first thing affected due to hypovolemia is preload)

Medications (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions